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BACKGROUND: We have previously shown that incuba-
tion of human endothelial cells with mast cell
granules results in potentiation of lipopolysacchar-
ide-induced production of interleukin-6 and interleu-
kin-8.
Aims: The objective of the present study was to
identify candidate molecules and signal transduction
pathways involved in the synergy between mast cell
granules and lipopolysaccharide on endothelial cell
activation.
Methods: Human umbilical vein endothelial cells
were incubated with rat mast cell granules in the
presence and absence of lipopolysaccharide, and IL-6
production was quantified. The status of c-Jun amino-
terminal kinase and extracellular signal-regulated
kinase 1/2 activation, nuclear factor-kB translocation
and intracellular calcium levels were determined to
identify the mechanism of synergy between mast cell
granules and lipopolysaccaride.
Results: Mast cell granules induced low levels of
interleukin-6 production by endothelial cells, and
this effect was markedly enhanced by lipopolysac-
charide. The results revealed that both serine pro-
teases and histamine present in mast cell granules
were involved in this activation process. Mast cell
granules increased intracellular calcium, and acti-
vated c-Jun amino-terminal kinase and extracellular
signal-regulated kinase 1/2. The combination of
lipopolysaccharide and mast cell granules prolonged
c-Jun amino-terminal kinase activity beyond the
duration of induction by either stimulant alone and
was entirely due to active proteases. However, both
proteases and histamine contributed to calcium
mobilization and extracellular signal-regulated ki-
nase 1/2 activation. The nuclear translocation of
nuclear factor-kB proteins was of greater magnitude
in endothelial cells treated with the combination of
mast cell granules and lipopolysaccharide.
Conclusions: Mast cell granule serine proteases and
histamine can amplify lipopolysaccharide-induced
endothelial cell activation, which involves calcium
mobilization, mitogen-activated protein kinase acti-
vation and nuclear factor-kB translocation.
Key words: Histamine, Serine protease, Lipopolysacchar-
ide, Endothelial cells
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Introduction
Vascular endothelium functions as a selective barrier
between blood and tissues, and regulates many
aspects of the inflammatory and immune responses.
The activation of endothelial cells, with resultant
syntheses of both pro-inflammatory and anti-inflam-
matory mediators and the expression of adhesion
molecules, is critical for immune surveillance and
disease progression.
1 4
Mast cells are integral constituents of the vessel
wall, and their numbers are elevated in vascular
diseases such as atherosclerosis.
5 7 When activated,
mast cells release vasoactive amines, prostaglandins,
leukotrienes, cytokines, proteoglycans, and proteases
that are potent modulators of endothelial cell func-
tion.
5 Previous reports from our laboratory have
shown that incubation of human endothelial cells
with rat mast cell granules (MCG) resulted in
potentiation of lipopolysaccharide (LPS)-induced in-
terleukin (IL)-6 and IL-8 production.
8,9 Further stu-
dies have shown that LPS-induced production of IL-6
by human umbilical vein endothelial cells (HUVECs)
was amplified by protease-activated receptor (PAR)
agonist peptides
10 and histamine.
11 These results
indicated that at least two components of the MCG,
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79proteases and histamine, participate in LPS-induced
synergy of endothelial cell activation. Activation of
endothelial cells by extracellular stimuli involves
participation of various signal transduction pathways
including intracellular Ca
2 , mitogen-activated pro-
tein (MAP) kinase activity, and nuclear factor (NF)-kB
translocation.
12 15 The purpose of this study was to
evaluate the relative contribution of proteases and
histamine in MCG-mediated endothelial cell activa-
tion, and to identify the signal transduction pathways
that are involved in this process. The results pre-
sented in this report demonstrate that MCG are
capable of inducing intracellular Ca
2  mobilization,
activation of MAP kinases, and translocation of NF-
kB, and that both serine proteases and histamine
present in MCG participate in the potentiation of LPS-
induced endothelial cell activation.
Materials and methods
Materials
HUVECs, endothelial cell growth medium-2 with the
recommended growth factors, N-2-hydroxyethylpi-
perazine-N?-2-ethane-sulfonic acid, Hank’s balanced
salt solution, trypsin-ethylenediaminetetraacetate
(EDTA), trypsin neutralizing solution, and trypsin
were purchased from Clonetics (San Diego, CA,
USA). Minimum Essential Medium and fetal bovine
serum were purchased from Hyclone Laboratories
(Logan, UT, USA). Heparin, penicillin, streptomycin,
metrizamide, Escherichia coli LPS and the protease
inhibitor cocktail were obtained from Sigma Chemi-
cal Co. (St Louis, MO, USA). g-[
32P]-adenosine tripho-
sphate (ATP) was supplied by New England Nuclear
(Boston, MA, USA). The enzyme-linked immunosor-
bant assay (ELISA) kits for IL-6 were purchased from
R & D systems (Minneapolis, MN, USA). Calcium
crimson and Fluo-4 were purchased from Molecular
Probes (Eugene, OR, USA). The NF-kB-specific
oligonucleotide and its complimentary strand were
synthesized at the Biotechnology Support Facility of
the University of Kansas Medical Center. Protein A/G-
coated agarose beads, glutathione-S-transferase
(GST)-c-Jun, anti-goat and anti-mouse immunoglo-
bulin G (IgG)-horseradish peroxide, polyclonal anti-
bodies against c-Jun amino-terminal kinase (JNK1)
(C-17), extracellular signal-regulated kinase-1 (ERK)1
(C-16) and ERK2 (C-14), and monoclonal IgG against
phosphorylated ERK (p-ERK), which recognizes both
phosphorylated ERK1 and ERK2, were obtained from
Santa Cruz (Santa Cruz, CA, USA). MAP kinase kinase
(MEK) inhibitor PD98059 was purchased from Cal-
biochem (San Diego, CA, USA). Bradford protein
assay reagents were purchased from Bio-Rad (Her-
culus, CA, US). Nitrocellulose membrane and western
blotting detection reagents were purchased from
Amersham (Piscataway, NJ, USA). All other reagents
were supplied by Fisher Scientific (Pittsburgh, PA,
USA).
Culture of HUVECs
HUVECs were grown in endothelial cell growth
medium-2 containing the recommended growth
factors and 5% fetal bovine serum at 378Ci na
humidified atmosphere containing 5% CO2. The cells
used in all experiments were between three and six
passages.
Preparation of mast cell granules
Three-month-old to four-month-old Sprague /Daw-
ley rats (300 /400 g) were the source of peritoneal
mast cells. The rats were euthanized using inhaled
Halothane. The methods employed for the isolation
of mast cells and MCG have been described pre-
viously.
8,16 MCG were aliquoted and frozen at   /208C
until use. The concentrations of MCG used in each
experiment were expressed as the equivalent of the
starting mast cell number.
Treatment of MCG with phenylmethylsulfonyl
fluoride
MCG were treated with medium or the serine
protease inhibitor phenylmethylsulfonyl fluoride
(PMSF) (1 mmol/l) for 12 h at 48C, and were dialyzed
against 100 mmol/l of Tris (pH 7.5) for 4 h with three
changes of buffer.
Measurement of protease activity and histamine
levels in MCG
Aliquots of PMSF-treated and control MCG prepara-
tions were analyzed for their protease activity and
histamine content. The serine protease activity (chy-
mase) in MCG preparation was assayed spectro-
photometrically at 405 nm by monitoring the
hydrolysis of succinyl-phenylalanyl-leucyl-phenyla-
nyl-p-nitroanalide. The reaction was carried out at
378C in 150 mmol/l of Tris (pH 7.6) in the presence of
1 mmol/l of substrate and the MCG preparation
(equivalent to 0.5 million mast cells) in a final volume
of 1 ml. The enzyme activity was continuously
monitored and the rate of reaction was calculated
using the extinction coefficient of 8800/M/cm for p-
nitroanalide as described elsewhere.
17 Histamine
content in mast cell granules was quantified using
an immuno-competition assay at the IBT Reference
Laboratory (Lenexa, KS, USA) using a commercially
available ELISA kit.
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HUVECs (10,000) were added to each of the wells of
a 96-well microtiter plate and allowed to adhere for
24 h. Following adherence, activating stimuli or
medium were added to the monolayers and the final
volume adjusted to 0.2 ml. The cells were incubated
for the indicated time periods at 378C under the
atmosphere of 5% humidified CO2. After the incuba-
tion, the culture supernatants were analyzed for IL-6
levels by ELISA according to the manufacturer’s
protocol.
Determination of intracellular calcium
mobilization
HUVECs were plated on glass cover slips and
allowed to grow to confluency within 48 h. Aliquots
of MCG equivalent to 3 /10
5 mast cells were added
to cover slips on which monolayers of HUVECs (6 /
10
5) were grown. Cells were incubated with the
Ca
2 -sensing fluorophore, Fluo-4 (1 mmol/l), for 45
min at 378Ci n5 %C O 2. Cover slips were placed in a
Fluorochamber on an Olympus Fluoview 300 Con-
focal Microscope. Cells were illuminated with an
argon laser at 488 nm and emitted light was detected
at 510 nm. Images were captured every 6 sec over a
10-min period. In additional experiments, the cells
were imaged on an inverted Nikon microscope with a
SPOT fluorescence sensing camera. In this case, cells
were loaded with the Ca
2  indicator calcium crim-
son. Background images were collected from each
field and digitally subtracted from the regions of
interest. Images were analyzed with the Fluoview
and Photoshop software, allowing mean fluores-
cence values to be obtained from individual cells
over time. In order to normalize for variations in dye
loading, the initial three fluorescence values for each
cell were averaged to determine the basal fluores-
cence level. This value was referred to as Fo. Each
subsequent fluorescence value (F) was divided by Fo,
and the F/Fo ratio provides a clear illustration of
changes in Ca
2  over time. Statistical analysis of
fluorescence values was completed using SigmaStat.
Assay of JNK activity
Confluent HUVEC monolayers were treated with
indicated concentrations of MCG in the presence or
absence of LPS at 378C for selected periods of time.
After incubation, the cells were lysed with Triton
Lysis Buffer (TLB) containing 20 mmol/l of Tris (pH
7.4), 137 mmol/l of NaCl, 10% (vol/vol) glycerol, 1%
(vol/vol) Triton X-100, 2 mmol/l of EDTA, 25 mmol/l
of b-glycerolphosphate, 2 mmol/l of sodium pyro-
phosphate, 1% (vol/vol) protease inhibitor cocktail
and 0.5 mmol/l of dithiothereitol at 48C for 30 min.
Cell debris was removed by centrifugation of the
lysate at 13,000 /g for 10 min. After quantification of
the protein content, samples were incubated with 40
ml of protein A/G-coated agarose beads and 0.6 mgo f
goat polyclonal antibody against JNK1 for 2 h at 48C.
The beads were washed by centrifugation and
resuspended in TLB buffer and, thereafter, kinase
buffer (25 mmol/l of hydroxyethylpiperazine-N?-2-
ethane-sulfonic acid (pH 7.5), 12.5 mmol/l of MgCl2,
25 mmol/l of b-glycerolphosphate supplemented
with 1 mmol/l of sodium orthovandate and 0.5
mmol/l of dithiothereitol). Each sample was incu-
bated with GST-c-Jun as the substrate for JNK1 in the
presence of 0.1 mmol/l of unlabeled ATP, 5 mCi of g-
[
32P]ATP, and kinase buffer in a volume of 20 ml for 15
min at 308C. Thereafter, reactions were terminated by
boiling in 2 / sodium dodecyl sulfate (SDS) sample
buffer for 5 min. Samples were subsequently sub-
jected to electrophoresis on 12% SDS-polyacrylamide
gel and visualized by autoradiography. Protein loads
were monitored in western blot using anti-JNK1
antibody.
Assay of phosphorylated ERK1/2
Confluent HUVEC monolayers were incubated with
indicated concentrations of MCG or histamine.
Whenever applicable, the incubations also contained
diphenhydramine and PD98059 to block H-1 recep-
tors and MEK-1 activation, respectively. After treat-
ment with indicated agents, the cells were lysed with
TLB at 48C for 30 min. Cell debris was removed by
centrifugation at 13,000 /g for 10 min. After quanti-
fication of the protein content in the supernatants,
aliquots normalized for protein concentrations were
mixed with equal volumes of 2 / SDS sample buffer
and heated to 1008C for 10 min. Samples were
electrophoresed on 12% SDS-polyacrylamide gels
and transferred onto a nitrocellulose filter. The filter
was treated with 5% non-fat milk in phosphate-
buffered saline and incubated with the antibody
specific for phosphorylated ERK1/2. The reaction
was detected by enhanced chemiluminescence. Pro-
tein loads were monitored by western blot using anti-
ERK1/2 antibody.
NF-kB activation and assay
To evaluate the role of NF-kB in MCG-mediated and
LPS-mediated activation of endothelial cells, the
nuclear NF-kB proteins were analyzed by electro-
phoretic mobility shift assay (EMSA). Confluent
HUVEC monolayers were treated with MCG, LPS or
the combination of MCG and LPS for the indicated
time intervals at 378C. Preparation of nuclear extracts
was performed as described previously.
18,19 EMSA
was carried out utilizing specific oligonucleotide
containing NF-kB binding site 5?-AGTTGAGGG-
GACTTTCCCAGGC-3?. The specific oligonucleotide
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then end-labeled using g-[
32P]ATP and T4-polynu-
cleotide kinase. Nuclear protein extracts (1 mg) were
mixed with 3 mg of poly(dI /dC).poly(dI /dC) and  /
2 ng (100,000 /400,000 cpm) of end-labeled DNA in
30 ml of EMSA buffer and incubated for 30 min at
258C. The EMSA buffer for NF-kB consisted of 10
mmol/l of Tris /HCl (pH 7.5) containing 40 mmol/l of
NaCl, 1 mmol/l of EDTA, 1 mmol/l of b-mercap-
toethanol, 4% glycerol, 0.1% NP-40 and 15 mmol/l of
bovine serum albumin. Following the initial binding
reaction, 20 ml of the mixture was electrophoresed at
150 V for 3 h at 258C through a native 6% poly-
acrylamide gel, which was prepared in 45 mmol/l of
Tris-borate buffer containing 1 mmol/l of EDTA. After
electrophoresis, the gel was dried and processed for
autoradiography.
Results
Effect of MCG on LPS-induced IL-6 production
by HUVECs
The results depicted in Fig. 1 demonstrate the effects
of MCG on naı ¨ve and LPS-activated HUVECs. Produc-
tion of IL-6 by HUVECs was detected as early as 2 h
after incubation with MCG. IL-6 production gradually
increased and plateaued by 8 h, and remained
unchanged throughout the remaining 48 h. In the
presence of LPS, production of IL-6 induced by MCG
was significantly amplified during the 48-h incuba-
tion period. Dialysis of MCG, which removed  /99%
of histamine (9158 and 0.19 ng/10
6 mast cell equiva-
lent for control and dialyzed MCG, respectively)
decreased endothelial cell IL-6 production by 40 /
60% either in the presence or absence of LPS.
Inhibition of serine protease activity in MCG by
treatment with PMSF (0.72 and 0 U/10
6 mast cell
equivalent for control and PMSF-treated MCG, re-
spectively) and depletion of histamine completely
abolished the direct and modulating effect.
Effect of MCG and LPS on Ca
2  mobilization in
HUVECs
The effect of MCG, LPS and the combination of MCG
and LPS on Ca
2  mobilization in HUVECs was
studied. Transient changes in free intracellular Ca
2 
were measured in confluent monolayers of HUVEC
using fluorescent markers. The time course and
magnitude of responses for MCG, LPS and the
combination are shown in Fig. 2A. The kinetics of
transient changes in Ca
2  was similar for all agonists
with each agonist added 2 min into the experiment.
The peak transient changes in Ca
2  were plotted for
each of the agonists as shown in Fig. 2B. F/Fo values
for control cells bathed in media over 6 min were
0.879 /0.04 (n /53 cells), demonstrating the level of
photobleaching that the fluorophore underwent with
normal laser illumination. Exposure to LPS (100 ng/
ml) induced a rapid increase in fluorescence indicat-
ing rising Ca
2  levels (F/Fo /1.479 /0.07; n /78).
Application of MCG caused a greater transient peak-
ing at 2.219 /0.18 (n /66). Dialysis of MCG, which
removed histamine, blunted the MCG response to
1.199 /0.14 (n /24). Inhibition of serine protease
activity by treatment with PMSF and subsequent
dialysis completely abrogated the effect of MCG
(0.849 /0.03; n /16). The combined application of
MCG and LPS caused a peak transient change that
was only slightly greater than MCG alone (F/Fo /
2.339 /0.13; n /41).
Effect of MCG and LPS on JNK activation in
HUVECs
Activation of JNK plays a significant role in signal
transduction pathways in endothelial cells.
20 22
Therefore, JNK activity was evaluated after activation
FIG. 1. Kinetics of IL-6 production by LPS-activated and MCG-
activated HUVECs. HUVEC monolayers (10,000) were cul-
tured with PMSF-treated and dialyzed MCG, dialyzed MCG or
intact MCG (5000 mast cell equivalents) in the absence (A)
and presence (B) of 100 ng/ml of LPS for the time intervals
indicated. IL-6 concentrations in the culture media were
assayed by ELISA. Values are the mean9 /standard error of
the mean of quadruplicate culture wells.
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Incubation of HUVECs with MCG resulted in low
level activation of JNK1 between 30 and 60 min,
which returned to basal levels by 3 h. Incubation of
HUVECs with LPS stimulated peak JNK activity at 3 h,
which returned to baseline by 6 h (data for 1 and 4 h
not shown). However, simultaneous exposure of
HUVECs to LPS and MCG prolonged the activation
of JNK1 for up to 8 h. The results presented in Fig. 1
and those reported previously
10,11 demonstrate that
both mast cell protease and histamine are involved in
MCG-induced endothelial cell activation. Therefore,
to further assess the role of proteases and histamine
on MCG-induced JNK activation, MCG were incu-
bated with PMSF (1 mmol/l) and then subjected to
dialysis. The treatment of MCG with PMSF completely
inhibited serine protease (chymase) activity, and
dialysis depleted the histamine content. As depicted
in Fig. 3, the depletion of histamine alone did not
affect MCG’s ability to induce JNK1 activation. On the
other hand, inhibition of protease activity by PMSF
treatment abolished the ability of MCG to prolong
LPS-induced activation of JNK1.
Effect of MCG on ERK1/2 phosphorylation in
HUVECs
ERK is a recognized signaling pathway in endothelial
cell activation.
23,24 Results presented in Fig. 4 show
that MCG stimulated ERK1/2 activation in HUVECs as
determined by quantification of p-ERK by western
blot. Incubation of HUVECs with MCG at an en-
dothelial cell to mast cell ratio of 2:1 resulted in
marked increase in p-ERK at 10 min, which peaked at
30 min and decreased with time to the basal level
within 2 h (Fig. 4A). As noted in Fig. 4B, the
activation of ERK was MCG dose dependent, and
plateaued at the endothelial cell to mast cell ratio of
2:1. MCG-induced ERK1/2 phosphorylation was
completely blocked by MEK inhibitor PD98059
25 at
a concentration of 30 mmol/l, confirming the involve-
ment of MEK activation (data not shown).
Mast cell granules depleted of both active protease
and histamine failed to induce ERK1/2 activation (Fig.
5A). Our previous study has shown that the effect of
histamine on endothelial cell production of proin-
flammatory cytokines is completely abolished by the
H-1 receptor antagonist diphenhydramine, but not by
the H-2 antagonist famotidine.
11 To further explore
the direct role of histamine in MCG-induced ERK
activation in HUVECs, studies were conducted with
the H-1 receptor antagonist diphenhydramine. As
shown in Fig. 5B, histamine-induced ERK1/2 activa-
tion was completely abrogated by diphenhydramine
(25 mmol/l), whereas MCG-induced effects were only
partially inhibited. These results indicate that both the
serine protease and histamine present in MCG are
capable of independently activating ERK1/2.
Activation of NF-kB proteins
Promoters of the IL-6 gene contain recognition
sequences for the transcription factor NF-kB.
26,27
EMSAs were carried out using nuclear extracts of
HUVECs to examine the effects of MCG and LPS on
NF-kB translocation. The exposure of HUVECs to
MCG in the presence of LPS for 3 h substantially
increased translocation of NF-kB proteins to the
FIG. 2. (A) Time course of MCG-induced and LPS-induced
intracellular Ca
2  levels. Fluo-4-labeled HUVECs (6 /10
5)
were monitored with confocal microscopy during stimula-
tion with LPS (100 ng/ml), MCG (3 /10
5 mast cell equiva-
lents), and a combination of both agonists (applied at the
arrow). The data are plotted as F/Fo as described in the
Materials and methods section. The ﬂuorescence values
(indicating free intracellular Ca
2 ) increased after the addi-
tion of each agonist. Each data point represents the mean9 /
standard error of the mean. This is representative of three
experiments. (B) MCG-induced and LPS-induced peak tran-
sient changes in intracellular Ca
2  levels. Peak Ca
2  tran-
sient changes (obtained within 2 /4 min) were plotted
summarizing all experiments. The data are plotted as F/Fo
as described in the Materials and methods section. The
results presented are from one of three similar experiments
using two different ﬂuorophores (calcium crimson and Fluo-
4) on both a confocal microscope and a SPOT ﬂuorescence
microscope. In total, over 150 cells were analyzed for each
condition except for dialyzed MCG. Each bar represents the
mean9 /standard error of the mean.
Signal transduction pathways in mast cell granule-mediated endothelial cell activation
Mediators of Inflammation Vol 12  2003 83nuclei (Fig. 6). The exposure of HUVECs to MCG
alone caused an increase in NF-kB protein levels in
the nuclei, which was of lesser magnitude than that
induced by LPS. Both the MCG-induced and LPS-
induced NF-kB translocation returned to baseline by
8 and 16 h, respectively. The augmented levels of
nuclear NF-kB proteins in HUVECs treated with the
combination of MCG and LPS decreased gradually
but remained elevated throughout the 24-h period.
Discussion
Mast cells and their granules contain effector mole-
cules that modulate functions of a variety of cells,
including macrophages and endothelial cells.
8,9,16,28
The results presented here reveal that MCG directly
activate human endothelial cells to release low levels
of IL-6. The MCG-induced endothelial cell activation
was greatly enhanced when HUVECs were simulta-
neously exposed to LPS. The effect of MCG on
FIG. 3. Kinetics of JNK activation in HUVECs after stimulation with MCG and LPS. Conﬂuent HUVECs (5 /10
6) were stimulated
with MCG, dialyzed MCG or dialyzed PMSF-treated MCG (2.5 /10
6 mast cell equivalents) alone or in a combination with LPS.
Cell lysates were prepared after the indicated time intervals. Immune complex kinase assays were performed as described in
Materials and methods using GST-c-Jun as a substrate for JNK. Protein loads were monitored by western blot using anti-
JNK1 antibody. Similar results were noted in two additional experiments.
FIG. 4. The kinetics of MCG-mediated ERK1/2 activation in
HUVECs. Conﬂuent HUVECs (5 /10
6) were treated with MCG
(2.5 /10
6 mast cell equivalents) for the time intervals
indicated (A) or treated with the indicated doses of MCG
for 30 min (B). After treatments, cell lysates were prepared
and subjected to SDS-polyacrylamide gel electrophoresis
followed by immunoblotting with phospho-speciﬁc ERK1/2
monoclonal antibody. Protein loads were monitored by
western blot using ERK1/2 antibodies. Similar results were
obtained in three experiments.
FIG. 5. The involvement of proteases and histamine in MCG-
induced activation of ERK1/2. Conﬂuent HUVECs (5 /10
6)
were incubated with MCG, dialyzed MCG, PMSF-pretreated
and dialyzed MCG (2.5 /10
6 mast cell equivalents) (A), or
with histamine (25 mmol/l) in the absence and presence of
diphenhydramine (25 mmol/l) (B) for 30 min. After the
treatments, cell lysates were prepared and subjected to
SDS-polyacrylamide gel electrophoresis followed by immu-
noblotting with phospho-speciﬁc ERK1/2 monoclonal anti-
body. Protein loads were monitored by western blot using
ERK1/2 antibodies. Similar results were obtained in three
experiments.
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decreased when their histamine content was de-
pleted. On the other hand, when both histamine
and serine protease activity were absent, MCG failed
to induce endothelial cell activation. These results are
in agreement with our previous reports, which
demonstrated a significant synergy between MCG
and LPS on endothelial cell production of IL-6 and IL-
8,
8,9 and that both histamine and serine proteases
present in MCG participate in the induction of
cytokine production.
9 11 The results of the present
study demonstrate that the MCG serine protease-
induced endothelial cell activation involves mobiliza-
tion of intracellular Ca
2 , activation of JNK and
ERK1/2, and increased translocation of NF-kB. His-
tamine independently or when present in the MCG
stimulates endothelial cells through the type 1
histamine receptor by increasing intracellular Ca
2 
and activating ERK1/2.
Mobilization of Ca
2  is an important event in
receptor-mediated activation and involves inositol
phosphate turnover and protein kinase C activa-
tion.
29 Proteases, LPS and histamine are known to
induce increases in intracellular Ca
2 .
30 32 Our
previous studies with protease activated-receptor
agonists demonstrated no correlation between in-
crease in intracellular Ca
2  and the production of IL-
6.
10 In the present study, both MCG and LPS induced
comparable changes in intracellular Ca
2 , and a
combination of these two agonists did not give an
additive effect. In contrast, the combination of MCG
and LPS synergized endothelial cell cytokine produc-
tion.
8,9 The results suggest that the magnitude of
Ca
2  mobilization does not directly relate to the level
of endothelial cell cytokine production. It is apparent
that both serine proteases and histamine contribute to
MCG-mediated increase in intracellular Ca
2 .
The MAP kinases, ERK, p38 and JNK, are involved
in endothelial activation.
20 24 The present results
demonstrate that MCG-stimulated JNK1 activation in
HUVECs occurs within 30 /60 min of exposure. The
kinetics of JNK1 activation by MCG is distinctly
different to that of LPS, which peaked between 1
and 3 h (data not shown) and dissipated by 6 h. The
treatment of HUVECs with a combination of LPS and
MCG provided strong and sustained JNK1 activity for
up to 8 h, which was not noted with either agonist
alone. Pretreatment of MCG with PMSF, the serine
protease inhibitor, completely abolished MCG-in-
duced prolongation of JNK1 activity. On the other
hand, MCG-induced JNK1 prolongation was unaf-
fected by depletion of histamine from MCG. This was
further supported by the finding that histamine
neither directly activated nor prolonged LPS-induced
JNK1 activation (data not shown). The failure by
histamine to induce JNK1 activation is consistent with
the lack of JNK activation by histamine in hamster vas
deferens smooth muscle cells.
33 There are two
plausible explanations for the sustained JNK1 activa-
tion by MCG protease. It has been demonstrated that
LPS elevates the expression of PAR-2 on endothelial
cells,
34 and that serine proteases activate PARs.
31
Therefore, the serine proteases in MCG may activate
the newly expressed PARs on HUVECs to induce a
second phase of JNK activation. Alternatively, MAP
kinase phosphatase-1 (MKP-1) and MKP-2 have been
implicated in the termination of JNK activity.
35 Since
MCG are endocytosed by HUVECs,
8 these organelles
containing proteases may inhibit MKP-1 and MKP-2,
and permit the prolongation of LPS-induced JNK
activation.
Incubation of HUVECs with MCG resulted in
significant activation of ERK1/2 in a concentration-
dependent and time-dependent manner. The effect
of MCG-mediated activation of ERK1/2 was partially
abrogated when histamine was depleted or by the
addition of H-1 receptor antagonist dyphenhydra-
mine. When MCG preparations were pretreated with
PMSF and subsequently dialyzed, ERK1/2 activation
FIG. 6. Electrophoretic mobility shift assay of nuclear NF-kB
translocation in HUVECs treated with MCG and LPS. Con-
ﬂuent monolayers of HUVECs (5 /10
6) were incubated with
MCG (2.5 /10
6 mast cell equivalents) in the presence or
absence of LPS (100 ng/ml) at 378C for time intervals as
indicated. The nuclear proteins extracted from the cells were
incubated with g-[
32P]-labeled oligonucleotide containing
NF-kB binding sites. The samples were subjected to electro-
phoresis on polyacrylamide gels, and the bands were
identiﬁed by autoradiogragh. The ampliﬁcation of LPS-
induced NF-kB translocation by MCG was also noted in
three other experiments.
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protease-free and histamine-free MCG was correlated
with the failure to induce IL-6 production and
synergize LPS-induced endothelial cell activation.
The present result on the effect of histamine on
ERK1/2 activation in endothelial cells is consistent
with the report by Gudmundsdottir et al.
36 It is
noteworthy that both serine proteases and histamine
present in MCG are involved in the activation of
ERK1/2, whereas only proteases participate in the
activation of JNK. The activation of ERK1/2 by mast
cell protease is in agreement with the recent finding
of ERK1/2 activation by tryptase in human eosino-
phils.
37 Several reports in the literature implicate LPS-
induced ERK1/2 activation in endothelial cells.
38 40
However, LPS did not activate ERK1/2 in our system
and therefore the combined effect of MCG and LPS
on ERK1/2 activity was not assessed. The lack of ERK
activation by LPS may be explained by the deficiency
of soluble CD14 and LPS binding proteins in the 72-h
conditioned media that were used in our study to
avoid serum-induced spontaneous ERK activation.
A number of studies have demonstrated the role of
NF-kB in the regulation of IL-6 production.
26,27 The
present study confirms that MCG, containing hista-
mine and serine proteases, cooperate with LPS to
synergize NF-kB translocation in HUVECs. Our pre-
vious study also demonstrated that activation of
endothelial cells by PAR agonists
10 and histamine
11
resulted in NF-kB translocation, both of which were
amplified by LPS. It is apparent that activation of at
least two MAP kinase pathways, ERK1/2 and JNK1,
are involved in the observed activation of endothelial
cells by MCG and LPS. The distinct patterns by which
MCG activates JNK1 and ERK1/2 are noteworthy in
explaining the synergy between MCG mediators and
LPS. Activation of JNK results in enhancement of
nuclear c-Jun protein and AP-1 binding,
41 and
augmented formation of c-Jun is known to induce
endothelial cell activation.
42,43 Therefore, the pro-
longed activation of LPS-induced JNK by MCG is
expected to enhance AP-1 binding to the promoters
of IL-6 and IL-8. On the other hand, the direct
activation of ERK1/2 by MCG will enhance c-Fos,
which in turn can associate with c-Jun to form stable
heterodimers
44 for sustained gene transcription.
Thus, the amplification of LPS-induced endothelial
cytokine production by MCG may be explained by
the coordinated generation of c-Jun and c-Fos, and
the enhanced translocation of NF-kB.
In summary, the present study demonstrates that
MCG-mediated and LPS-mediated endothelial cell
activation utilizes an increase in intracellular Ca
2 ,
translocation of NF-kB, activation of JNK1 and ERK1/
2, and that both serine proteases and histamine
residing in MCG participate in potentiating the effects
of LPS. These findings suggest that the combined
effects of MCG mediators and LPS can induce
amplified endothelial cell activation. Therefore,
mast cell degranulation together with bacterial infec-
tion may create a favorable environment for en-
hanced vascular inflammation.
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